Welcome to our dedicated page for TRULIEVE CANNABIS news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on TRULIEVE CANNABIS stock.
Trulieve is a leading cannabis company with a focus on providing relief to patients through trusted products. Hand-grown plants in a natural environment ensure quality and purity at every step. Trulieve is a vertically integrated, multi-state operator with a strong market presence in Arizona, Florida, and Pennsylvania. The company's innovative products, high-quality brands, and commitment to customer experience make it a top choice for those seeking access to cannabis products.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the launch of a diverse brand portfolio to enhance its market offerings in the U.S. The portfolio includes four distinct brands: Muse™, Sweet Talk™, Momenta™, and the Cultivar Collection™, catering to various consumer needs from casual users to connoisseurs. The new brands were introduced in the Massachusetts market and are set for expansion pending regulatory approvals. The Cultivar Collection has been one of Trulieve's fastest-selling products since its launch in Florida in October 2020.
Trulieve Cannabis Corp has received an intent to award a Class 1 production license from the Georgia Access to Medical Cannabis Commission. This license enables Trulieve to establish operations in Georgia, expanding its footprint in the Southeastern U.S. The company will set up an indoor cultivation and manufacturing facility in Adel, focusing on low-THC oil products. This expansion is expected to create hundreds of jobs in Cook County and enhance local community investment. The move also bolsters Trulieve's commitment to medical cannabis education through a partnership with Morehouse School of Medicine.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the opening of its 96th dispensary in Florida, located in Winter Haven. This new 3,200 sq. ft. facility aims to enhance medical cannabis accessibility for patients in Central Florida, joining existing locations in Lakeland and Sebring. On opening day, patients can avail a 25% discount. Trulieve provides a wide range of THC and CBD products, home delivery, and virtual consultations. The company prioritizes safety by following CDC guidelines during the ongoing pandemic.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the opening of its 95th dispensary in Crystal River, Florida, on July 20, 2021. This new facility aims to provide safe access to medical cannabis for patients in Central Florida, complementing existing locations in The Villages, Lady Lake, and Ocala. To celebrate, all customers will receive a 25% discount on opening day. Trulieve offers Florida's largest selection of THC and CBD products and provides home delivery and virtual consultations for patient support. The company emphasizes safety measures amidst the COVID-19 pandemic.
Trulieve Cannabis Corp. (OTC: TCNNF) will announce its Q2 2021 financial results on August 12, 2021, before market opening. A conference call will follow at 8:30 AM ET to discuss the results. Interested participants can join by calling 1-877-870-4263 and entering conference ID 10158485. For those unable to attend live, an archived replay will be available until August 19, 2021, with details provided for accessing it. Trulieve is a leading cannabis company primarily operating in Florida and other states.
Trulieve Cannabis Corp. has completed a $60 million acquisition of Anna Holdings LLC, which holds dispensary permits for Keystone Shops in Philadelphia, Devon, and King of Prussia. The transaction includes $20 million in cash and the issuance of 1,009,336 subordinate voting shares. Trulieve aims to enhance its presence in the Greater Philadelphia area, adding to its total of 91 dispensaries nationwide. An additional $5 million is contingent on future laws permitting adult-use cannabis in Pennsylvania.
Trulieve Cannabis Corp. (OTCQX: TCNNF) has commenced operations in West Virginia, marking its entry into the state's medical cannabis market. The company has initiated cultivation at a 100,000 square foot facility in Huntington, aiming to provide quality products to the state's registered patients. As of June 30, 2021, there are 2,305 patients enrolled in West Virginia's medical cannabis program. Trulieve's commitment includes investing in local communities and hiring for various roles in West Virginia.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the completion of its asset purchase agreement to acquire a licensed adult-use dispensary in Worcester, Massachusetts, from Nature's Remedy for $13.5 million. This transaction comprises $7 million in cash and 237,881 subordinate voting shares. The acquired dispensary holds all necessary licenses to operate. CEO Kim Rivers expressed enthusiasm about expanding Trulieve's product offerings, including new edibles and vape lines, enhancing their customer service, and introducing quality genetics to the Massachusetts market.
Trulieve Cannabis Corp. has announced the opening of its 91st dispensary in Winter Park, Florida, aimed at enhancing access to medical cannabis for patients in Central Florida. The new location, opening on June 24, 2021, will offer a 25% discount on the first day to all patients. Trulieve provides a wide range of THC and CBD products, including edibles and vaporizers, with home delivery and in-store pickup options available. As the largest fully licensed medical cannabis company in Florida, Trulieve continues to ensure patient safety amid ongoing COVID-19 considerations.
FAQ
What is the current stock price of TRULIEVE CANNABIS (TCNNF)?
What is the market cap of TRULIEVE CANNABIS (TCNNF)?
What is Trulieve's core focus?
Where does Trulieve operate?
What sets Trulieve apart from other cannabis companies?
How does Trulieve ensure product quality?
What is Trulieve's approach to expansion?
